Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Epigenetic landscape of small cell lung cancer: small image of a giant recalcitrant disease
Parvez Κhan, Jawed A. Siddiqui, Shailendra Kumar Maurya, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 57-76
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC
Xing Niu, Lijie Chen, Yan Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 273-285
Closed Access | Times Cited: 175
Small cell lung cancer transformation: From pathogenesis to treatment
Xiaomeng Yin, Yueyi Li, Hang Wang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 595-606
Closed Access | Times Cited: 72
FOXM1: A small fox that makes more tracks for cancer progression and metastasis
Md Arafat Khan, Parvez Κhan, Aatiya Ahmad, et al.
Seminars in Cancer Biology (2023) Vol. 92, pp. 1-15
Open Access | Times Cited: 57
MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis
Parvez Κhan, Jawed A. Siddiqui, Prakash Kshirsagar, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 43
RNA-based therapies: A cog in the wheel of lung cancer defense
Parvez Κhan, Jawed A. Siddiqui, Imayavaramban Lakshmanan, et al.
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 77
Small cell lung cancer: Novel treatments beyond immunotherapy
Job-Joris Meijer, Alessandro Leonetti, Giulia Airò, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 376-385
Open Access | Times Cited: 69
m6A regulators as predictive biomarkers for chemotherapy benefit and potential therapeutic targets for overcoming chemotherapy resistance in small-cell lung cancer
Zhihui Zhang, Chaoqi Zhang, Zhaoyang Yang, et al.
Journal of Hematology & Oncology (2021) Vol. 14, Iss. 1
Open Access | Times Cited: 50
POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity
Aileen Patricia Szczepanski, Natsumi Tsuboyama, Jun Watanabe, et al.
Science Advances (2022) Vol. 8, Iss. 40
Open Access | Times Cited: 37
Mucins as Potential Biomarkers for Early Detection of Cancer
Shailendra K. Gautam, Parvez Κhan, Kavumpurathu Raman Thankappan, et al.
Cancers (2023) Vol. 15, Iss. 6, pp. 1640-1640
Open Access | Times Cited: 20
Small cell lung cancer transformations from non-small cell lung cancer: Biological mechanism and clinical relevance
Yang Yang, Songqing Fan
Chinese Medical Journal - Pulmonary and Critical Care Medicine (2024) Vol. 2, Iss. 1, pp. 42-47
Open Access | Times Cited: 6
The Regulatory Network and Potential Role of LINC00973-miRNA-mRNA ceRNA in the Progression of Non-Small-Cell Lung Cancer
Qiang Guo, Dan Li, Xiangyu Luo, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
m6A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancer
Zhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 38
Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer
Natsumi Tsuboyama, Ru Wang, Aileen Patricia Szczepanski, et al.
Oncogene (2022) Vol. 41, Iss. 15, pp. 2152-2162
Open Access | Times Cited: 25
mRNA Vaccine - A New Cancer Treatment Strategy
Tian Tan, Shuting Deng, Bing-Huo Wu, et al.
Current Cancer Drug Targets (2023) Vol. 23, Iss. 9, pp. 669-681
Closed Access | Times Cited: 16
Phosphorylation of AGO2 by TBK1 Promotes the Formation of Oncogenic miRISC in NSCLC
Xian Zhao, Yingting Cao, Runhui Lu, et al.
Advanced Science (2024) Vol. 11, Iss. 15
Open Access | Times Cited: 5
Emerging role of chemokines in small cell lung cancer: Road signs for metastasis, heterogeneity, and immune response
Parvez Κhan, Mahek Fatima, Md Arafat Khan, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 117-126
Open Access | Times Cited: 19
Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies
Massimiliano Cani, Valerio Maria Napoli, Edoardo Garbo, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 10, pp. 8883-8883
Open Access | Times Cited: 12
RNA-based Therapeutics: Past, Present and Future Prospects, Challenges in Cancer Treatment
Anjana Goel, Amisha Rastogi, M. Jain, et al.
Current Pharmaceutical Biotechnology (2024) Vol. 25, Iss. 16, pp. 2125-2137
Closed Access | Times Cited: 4
Deep analysis of the trials and major challenges in the first-line treatment for patients with extensive-stage small cell lung cancer
Ran Gao, Peizhu Wu, Xiaoyan Yin, et al.
International Immunopharmacology (2025) Vol. 148, pp. 114116-114116
Open Access
Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention
Lin Tang, Peng Shen, Xiaoying Zhuang, et al.
MedComm – Oncology (2025) Vol. 4, Iss. 1
Open Access
Metformin inhibits the growth of SCLC cells by inducing autophagy and apoptosis via the suppression of EGFR and AKT signalling
Hong Xia, Xuejiao Tai, Cheng Wang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Epigenetic modifications in early stage lung cancer: pathogenesis, biomarkers, and early diagnosis
Lingfeng Bi, Xin Wang, Jiayi Li, et al.
MedComm (2025) Vol. 6, Iss. 3
Open Access
Targeting the epigenetic processes to enhance antitumor immunity in small cell lung cancer
Hao Luo, Jinlu Shan, Hong Zhang, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 960-970
Open Access | Times Cited: 17
Overcoming multi-drug resistance in SCLC: a synergistic approach with venetoclax and hydroxychloroquine targeting the lncRNA LYPLAL1-DT/BCL2/BECN1 pathway
Shuxin Li, Jianyi Lv, Zhihui Li, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 3
MicroRNA-1: Diverse role of a small player in multiple cancers
Parvez Κhan, Nivetha Sarah Ebenezer, Jawed A. Siddiqui, et al.
Seminars in Cell and Developmental Biology (2021) Vol. 124, pp. 114-126
Open Access | Times Cited: 23
Page 1 - Next Page

Scroll to top